triple glp 1 retatrutide mechanism agonist glp-1 gip glucagon ly3437943 Beyond -1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence promoting overall digestive wellness Triple agonist designed to outperform
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5


























